Merck Sues Watson Labs To Block Generic Contraceptive

Law360, New York (June 5, 2013, 1:14 PM EDT) -- Merck & Cie and Bayer Pharma AG on Tuesday accused generic-drug maker Watson Laboratories Inc. of infringing the patent for their contraceptive Safyral by seeking approval for a generic version of the drug, according to identical suits filed in federal courts in Delaware and Nevada.

Switzerland-based Merck, which owns the patent for Safyral, and Bayer, the patent's exclusive licensee, asked the court for a permanent injunction barring Watson from manufacturing or selling its generic and preventing the U.S. Food and Drug Administration from approving it before...
To view the full article, register now.